Join our esteemed experts, Dr. Schreiber and Dr. Moon, as they explore our understanding of Alzheimer’s disease pathophysiology and the current treatment landscape. Through an interactive patient case study, our speakers will provide expert guidance on the LEQEMBI patient journey, including patient selection, diagnosis, treatment, and management. This will be supported by key efficacy and […] Read More
The initiative will begin by identifying hallmark aspects of neurofibromatosis type 1 natural history and clinical presentation, reviewing updated diagnostic criteria, and describing the genetic etiology and complex pathophysiology that has historically made neurofibromatosis type 1–associated plexiform neurofibromas so difficult to treat. Learners will then be guided through an expert-led exploration of established clinical trial […] Read More
The live symposium, led by two nationally recognized gMG experts and a clinical moderator, will provide an in-depth examination of generalized myasthenia gravis (gMG), focusing on the latest advancements in neonatal Fc receptor (FcRn) antagonist therapy. Experts will explore the mechanistic role of FcRn antagonism in gMG, its impact on albumin homeostasis, and current clinical […] Read More
Understand how ATTR amyloidosis impacts patients and learn new strategies for early diagnosis and successful monitoring of ATTRv-PN. Improve your clinical practice by applying evidence from trials in ATTR-PN settings to common care scenarios. Learn strategies for incorporating best practices from amyloid centers into your neurology practice. Faculty Co-Chair & Presenter Michelle C. Kaku, MD […] Read More